These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 25118673)

  • 1. Recent patents on calcium channel blockers: emphasis on CNS diseases.
    Arranz-Tagarro JA; de los Ríos C; García AG; Padín JF
    Expert Opin Ther Pat; 2014 Sep; 24(9):959-77. PubMed ID: 25118673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The design and discovery of T-type calcium channel inhibitors for the treatment of central nervous system disorders.
    Choi KH
    Expert Opin Drug Discov; 2013 Aug; 8(8):919-31. PubMed ID: 23659216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Possibilities of therapeutic applications of neuronal calcium homeostasis].
    Dobrovský K; Valchár M; Höschl C
    Cas Lek Cesk; 1991 Nov; 130(22-23):625-30. PubMed ID: 1664783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T-type calcium channel blockers: a patent review (2012-2018).
    Nam G
    Expert Opin Ther Pat; 2018 Dec; 28(12):883-901. PubMed ID: 30372652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T-type calcium channels inhibitors: a patent review.
    Giordanetto F; Knerr L; Wållberg A
    Expert Opin Ther Pat; 2011 Jan; 21(1):85-101. PubMed ID: 21087200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Voltage-dependent calcium channels.
    Lacinová L
    Gen Physiol Biophys; 2005 Jun; 24 Suppl 1():1-78. PubMed ID: 16096350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of voltage-dependent calcium channel blockers on ethanol-induced beta-endorphin release from hypothalamic neurons in primary cultures.
    De A; Boyadjieva NI; Sarkar DK
    Alcohol Clin Exp Res; 1999 May; 23(5):850-5. PubMed ID: 10371405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pleiotropic effects of new generation calcium channel blockers on cardiovascular protections].
    Ogimoto A; Higaki J
    Clin Calcium; 2013 Apr; 23(4):569-74. PubMed ID: 23545747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The diverse therapeutic actions of pregabalin: is a single mechanism responsible for several pharmacological activities?
    Stahl SM; Porreca F; Taylor CP; Cheung R; Thorpe AJ; Clair A
    Trends Pharmacol Sci; 2013 Jun; 34(6):332-9. PubMed ID: 23642658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of various K+ channel blockers on spontaneous glycine release at rat spinal neurons.
    Shoudai K; Nonaka K; Maeda M; Wang ZM; Jeong HJ; Higashi H; Murayama N; Akaike N
    Brain Res; 2007 Jul; 1157():11-22. PubMed ID: 17555723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiepileptic drugs on calcium currents recorded from cortical and PAG neurons: therapeutic implications for migraine.
    Martella G; Costa C; Pisani A; Cupini LM; Bernardi G; Calabresi P
    Cephalalgia; 2008 Dec; 28(12):1315-26. PubMed ID: 18771493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro characterization of T-type calcium channel antagonist TTA-A2 and in vivo effects on arousal in mice.
    Kraus RL; Li Y; Gregan Y; Gotter AL; Uebele VN; Fox SV; Doran SM; Barrow JC; Yang ZQ; Reger TS; Koblan KS; Renger JJ
    J Pharmacol Exp Ther; 2010 Nov; 335(2):409-17. PubMed ID: 20682849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spontaneous muscle action potentials are blocked by N-type and P/Q-calcium channels blockers in the rat spinal cord-muscle co-culture system.
    Taguchi K; Shiina M; Shibata K; Utsunomiya I; Miyatake T
    Brain Res; 2005 Feb; 1034(1-2):62-70. PubMed ID: 15713260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional and pharmacological consequences of the distribution of voltage-gated calcium channels in the renal blood vessels.
    Hansen PB
    Acta Physiol (Oxf); 2013 Apr; 207(4):690-9. PubMed ID: 23351056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuronal injury in chronic CNS inflammation.
    Zindler E; Zipp F
    Best Pract Res Clin Anaesthesiol; 2010 Dec; 24(4):551-62. PubMed ID: 21619866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New CNS-specific calcium antagonists.
    McBurney RN; Daly D; Fischer JB; Hu LY; Subbarao K; Knapp AG; Kobayashi K; Margolin L; Reddy NL; Goldin SM
    J Neurotrauma; 1992 May; 9 Suppl 2():S531-43. PubMed ID: 1319500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Omega-grammotoxin SIA blocks multiple, voltage-gated, Ca2+ channel subtypes in cultured rat hippocampal neurons.
    Piser TM; Lampe RA; Keith RA; Thayer SA
    Mol Pharmacol; 1995 Jul; 48(1):131-9. PubMed ID: 7623767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blockers of voltage-gated sodium channels for the treatment of central nervous system diseases.
    Tarnawa I; Bölcskei H; Kocsis P
    Recent Pat CNS Drug Discov; 2007 Jan; 2(1):57-78. PubMed ID: 18221218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular characterization of pyrrolo[2,1-d][1,5]benzothiazepine derivatives binding selectively to the peripheral-type benzodiazepine receptor (PBR): from dual PBR affinity and calcium antagonist activity to novel and selective calcium entry blockers.
    Campiani G; Fiorini I; De Filippis MP; Ciani SM; Garofalo A; Nacci V; Giorgi G; Sega A; Botta M; Chiarini A; Budriesi R; Bruni G; Romeo MR; Manzoni C; Mennini T
    J Med Chem; 1996 Jul; 39(15):2922-38. PubMed ID: 8709127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcium channel blockers in the treatment of disease.
    Elmslie KS
    J Neurosci Res; 2004 Mar; 75(6):733-41. PubMed ID: 14994334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.